Issuance of Stock Options for Employees
First written in FY2019. 2 of 8 entries say "Advanced", first in FY2020-Q1. Latest entry: FY2025-H1.
18 other companies' latest entry also says "Other".
- FY2025-H1All stock acquisition rights expiredAnnual report
「The stock acquisition rights expired because the conditions for vesting were not met. (Number of stock acquisition rights: 2,310; number of underlying shares: 231,000)」
The company disclosed that all 231,000 outstanding unvested shares under the employee stock options expired because the conditions for vesting were not met. - FY2024Decrease in balance due to expirationAnnual report
「Balance at end of previous consolidated fiscal year 246,500 Granted — Expired 15,500 Vested — Outstanding unvested 231,000」
For the employee stock options, rights covering 15,500 shares expired, reducing the outstanding unvested balance from 246,500 shares to 231,000 shares. - FY2023Decrease in balance due to expirationAnnual report
「Balance at end of previous consolidated fiscal year 261,000 Granted — Expired 14,500 Vested — Outstanding unvested 246,500」
For the employee stock options, rights covering 14,500 shares expired, reducing the outstanding unvested balance from 261,000 shares to 246,500 shares. - FY2022Decrease in balance due to expirationAnnual report
「Balance at end of previous consolidated fiscal year 279,000 Granted — Expired 18,000 Vested — Outstanding unvested 261,000」
For the employee stock options, rights covering 18,000 shares expired, reducing the outstanding unvested balance from 279,000 shares to 261,000 shares. - FY2021Decrease in balance due to expirationAnnual report
「Balance at end of previous consolidated fiscal year 298,000 Granted — Expired 19,000 Vested — Outstanding unvested 279,000」
For the employee stock options, rights covering 19,000 shares expired, reducing the outstanding unvested balance from 298,000 shares to 279,000 shares. - FY2020AdvancedAnnual report
「Employees of the company 206 Employees of the company’s subsidiaries 6 Common shares 298,000 (Note 1) Exercise period for stock acquisition rights※ 17 July 2021–16 July 2024」
For stock options covering 212 employees, 298,000 shares excluding expired rights have been confirmed as the outstanding unvested balance, and the exercise period has also been specified. - FY2020-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 20 June 2019, the company resolved the specific terms, as set out below, of the stock acquisition rights to be issued as stock options to employees of the company and its subsidiaries, based on Articles 236, 238 and 239 of the Companies Act and approval at the company’s 47th annual general meeting of shareholders, and hereby announces the resolution.」
The Board of Directors resolved the terms of the employee stock options, including allotments to 206 employees of the company and 6 employees of its subsidiaries, 300,000 common shares, and an exercise period from 17 July 2021 to 16 July 2024. - FY2019First statedAnnual report
「The company will issue stock acquisition rights as stock options to employees of the company and its subsidiaries at no charge, in accordance with the following terms, in order to further increase their motivation and morale to improve the company’s performance, secure talented personnel and contribute to increasing corporate value.」
The company disclosed for the first time a program to issue stock acquisition rights at no charge, covering up to 300,000 common shares, to improve employee morale, secure talented personnel and increase corporate value. The exercise period is 3 years beginning 2 years after the day following the allotment date.